Stockscreener 앱 받기
7.31
1.81%
0.13
시간 외 거래:
7.15
-0.16
-2.19%
전일 마감가:
$7.18
열려 있는:
$7.17
하루 거래량:
2.98M
Relative Volume:
1.42
시가총액:
$2.69B
수익:
$9.47B
순이익/손실:
$-178.00M
주가수익비율:
-15.23
EPS:
-0.48
순현금흐름:
$1.01B
1주 성능:
+18.67%
1개월 성능:
-2.14%
6개월 성능:
+25.39%
1년 성능:
-15.69%
1일 변동 폭
$7.10
$7.40
1주일 범위
$6.13
$7.49
52주 변동 폭
$3.96
$11.46
Bausch Health Companies Inc Stock (BHC) Company Profile
명칭
Bausch Health Companies Inc
전화
514-744-6792
주소
2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC
BHC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BHC
Bausch Health Companies Inc
|
7.31 | 2.69B | 9.47B | -178.00M | 1.01B | -0.48 |
|
ZTS
Zoetis Inc
|
160.46 | 71.85B | 9.26B | 2.49B | 2.30B | 5.47 |
|
HLN
Haleon Plc Adr
|
10.08 | 45.58B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.06 | 44.58B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.74 | 19.18B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
128.60 | 13.67B | 612.78M | -86.37M | -62.91M | -0.87 |
Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-02 | 다운그레이드 | Piper Sandler | Neutral → Underweight |
| 2024-07-10 | 개시 | Raymond James | Mkt Perform |
| 2023-09-20 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-16 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2022-07-29 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-07-29 | 다운그레이드 | Truist | Buy → Hold |
| 2022-07-28 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-06-13 | 재개 | JP Morgan | Overweight |
| 2021-03-24 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2021-02-17 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2021-01-22 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-09-17 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2020-08-24 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-17 | 재확인 | H.C. Wainwright | Buy |
| 2020-04-24 | 개시 | Citigroup | Buy |
| 2020-04-02 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-29 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2020-01-22 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2019-12-12 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2019-12-02 | 개시 | Goldman | Neutral |
| 2019-10-25 | 개시 | Cowen | Outperform |
| 2019-09-12 | 개시 | Guggenheim | Buy |
| 2019-08-15 | 업그레이드 | TD Securities | Hold → Buy |
| 2019-07-19 | 개시 | Wolfe Research | Outperform |
| 2019-06-11 | 재개 | Barclays | Overweight |
| 2019-05-13 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2019-03-20 | 개시 | SunTrust | Buy |
| 2019-01-02 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2018-11-05 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2018-09-13 | 업그레이드 | Piper Jaffray | Underweight → Neutral |
모두보기
Bausch Health Companies Inc 주식(BHC)의 최신 뉴스
Bausch Health Beats on Q4 Earnings and Revenues, Xifaxan Boosts Sales - MSN
Bausch Health Companies Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Why Bausch Health Companies Inc. (BHC) Went Up On Thursday? - Yahoo Finance
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Shareholders of Bausch Health Companies Inc.(BHC) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
Bausch Health Q4 Earnings Recap (Reiterating Buy Rating) (NYSE:BHC) - Seeking Alpha
‘New’ B+L? Wait Until Bausch Health Sells Stake - HBW Insight
Alibaba, Hasbro, Shake Shack, Bausch Health And Other Big Stocks Moving Higher On Thursday - Benzinga
Toronto Stocks Slip; Bausch Health Shares Climb on 4Q Beat, Rosy 2025 Outlook -February 20, 2025 at 12:24 pm EST - Marketscreener.com
Bausch Health Companies Inc. (NYSE:BHC) Q4 2024 Earnings Call Transcript - Insider Monkey
Bausch Health Companies Inc. SEC 10-K Report - TradingView
BAUSCH HEALTH COMPANIES INC. (NYSE:BHC) SHAREHOLDER ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Bausch Health Companies Inc. - ACCESS Newswire
Bausch Health projects $4.95B-$5.1B revenue for 2025 with focus on growth and innovation - MSN
Bausch Health Stock Pops After-Hours On Q4 Earnings Beat, Bullish Outlook: Retail Confidence Rises - MSN
Bausch: Q4 Earnings Snapshot - The Washington Post
Bausch Health Reports Strong 2024 Financial Performance - TipRanks
Bausch Health Companies Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
Compared to Estimates, Bausch (BHC) Q4 Earnings: A Look at Key Metrics - Nasdaq
Bausch Health (BHC) Q4 Earnings and Revenues Top Estimates - Nasdaq
Bausch Health Swings to Q4 Profit, Revenue Increases -- Shares Rise After Hours -February 19, 2025 at 05:27 pm EST - Marketscreener.com
Bausch Health Reports Strong 2024 Financial Results with Continued Growth - TipRanks
Bausch Health Shares Climb On Better-Than-Expected Q4 Revenue, Strong Forward Guidance - Benzinga India
Bausch Health Announces Fourth Quarter and Full-Year 2024 Results - Galveston County Daily News
Can Bausch Health's 7-Quarter Growth Streak Signal a Healthcare Sector Momentum Shift? - StockTitan
Bausch & Lomb aims to shake up contact lenses with deal off the table - Yahoo Finance UK
Bausch Health Companies Q4 2024 Earnings Preview - MSN
Revenues Working Against Bausch Health Companies Inc.'s (NYSE:BHC) Share Price - Simply Wall St
A Pharmaceutical Giant on the Brink: Will Bausch Health Break Even? - Jomfruland.net
Bausch Health Companies Inc. (NYSE:BHC) Could Be Less Than A Year Away From Profitability - Yahoo Canada Finance
Bausch Health Companies (BHC) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
Bausch Health cut to hold by Jefferies over B+L update - MSN
BHCBausch Health Companies Inc Latest Stock News & Market Updates - StockTitan
Bausch Health Companies (TSE:BHC) Trading Down 0.3%Here's Why - MarketBeat
Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference - Weatherford Democrat
Bausch Health Companies Inc. (NYSE:BHC) Receives $7.42 Consensus PT from Brokerages - MarketBeat
Bausch Health Defeats Shareholder Suit Over Spinoff, Drug Patent - Bloomberg Law
Bausch Health Beats Suit Over 'Faking' Financial Stability - Law360
Earnings Preview: Bausch Health (BHC) Q4 Earnings Expected to Decline - Yahoo Canada Finance
Skincare Devices Market and Competition Analysis 2025-2030, - GlobeNewswire
Skincare Devices Market and Competition Analysis 2025-2030, Featuring 42 Major Companies Including Alma Lasers, Bausch Health Companies, Lumenis, Merz Pharma & More - Yahoo Finance
Best Stock to Buy Right Now: WELL Health vs Bausch Health? - Yahoo Canada Finance
Coulter Partners places Chief Medical Officer and Head of R&D at Bausch Health - PharmiWeb.com
Stocks In Play: Bausch Health Companies Inc. By Baystreet.ca - Investing.com Canada
Bausch Health Companies Inc. - MENAFN.COM
Stocks In Play - Baystreet.ca
Bausch Health Announces 2025 Salix Gastrointestinal Health Scholars Program - Milton Daily Standard
Bausch Health's Salix Unveils Life-Changing $10K Scholarships for Students with GI Conditions - StockTitan
Bausch + Lomb ends sale process, to focus on 2025 plans - MSN
Bausch + Lomb provides update on potential sale - Ophthalmology Times
Private Management Group Inc. Cuts Stock Holdings in Bausch Health Companies Inc. (NYSE:BHC) - MarketBeat
Bausch & Lomb drops after ending sales process - MSN
Jefferies Financial Group Reaffirms "Hold" Rating for Bausch Health Companies (NYSE:BHC) - MarketBeat
Bausch Health Companies Inc (BHC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.23%
3.94%
자본화:
|
볼륨(24시간):